// App-Quantinova.ai

: Baseline predictors of being exacerbation-free during 2 years of benralizumab treatment

Researchers

Presenter

  • John W. Upham

Principal Investigators

  • David J. Jackson

  • Peter Barker

  • Paul Newbold

  • William Cook

Medical Centers

  • University of Queensland Diamantina Institute, Brisbane, Australia

  • Guy’s Severe Asthma Centre, Guy’s & St Thomas’ Hospitals; King’s College London, London, United Kingdom

  • AstraZeneca Gaithersburg, Gaithersburg, United States of America

Locations

  • Australia

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Benralizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved